Furosemide Injection Facing Ongoing Supply Challenges: FDA Shortage Update

What’s in Shortage

Furosemide Injection (Brand Name: FUROSEMIDE) is currently listed in a shortage status by the FDA. This medication is categorized as a cardiovascular therapeutic agent and is primarily supplied in various injection presentations, including 10 mg/1 mL, 20 mg/2 mL, 40 mg/4 mL, and 100 mg/10 mL vials. The shortage was first posted on April 7, 2020, and was most recently updated on February 3, 2026.

Which Manufacturers Are Affected

Availability varies significantly by manufacturer and specific product presentation:

• Accord Healthcare Inc.: All listed presentations are currently Unavailable. (Contact: 866-941-7875)
• Sagent Pharmaceuticals: Reporting Limited availability or Unavailable status. The manufacturer suggests using alternative NDCs (such as NDC 25021-320-02, 25021-320-04, or 25021-320-10) for certain presentations. (Contact: 866-625-1618)
• Eugia US LLC: The 100 mg/10 mL presentation is Available. However, the 20 mg/2 mL and 40 mg/4 mL presentations are Unavailable and on backorder with a recovery date to be determined. (Contact: 888-238-7880)
• Avet Pharmaceuticals, Inc.: Most presentations are Available. One specific presentation (NDC 23155-473-44) is Unavailable with an estimated availability date of March 23, 2026. (Contact: 855-228-9470)
• Fresenius Kabi USA, LLC: Presentations are currently Available. The manufacturer advises checking wholesalers for inventory. (Contact: 888-386-1300)
• Baxter Healthcare: Presentations are currently Available. (Contact: 888-229-0001)

Why There’s a Shortage

The FDA notes that the reason for the current shortage is related to requirements for complying with good manufacturing practices.

What Patients Should Do

If you or a loved one relies on Furosemide Injection, please consider the following steps:

• Consult Your Healthcare Provider: Discuss the shortage with your doctor to determine the best course of action for your specific medical needs.
• Speak with Your Pharmacist: Pharmacists often have the most up-to-date information on which specific NDCs are in stock or available through their wholesalers.
• Contact Manufacturers: If you have specific questions regarding the availability of a certain presentation, you may use the contact numbers provided above.

Disclaimer: This article is for informational purposes only. Patients should always consult with their healthcare provider or pharmacist regarding medication changes or medical advice.

Source

FDA Drug Shortage Database